Creating cellular diversity through transcription factor competition.
Change log
Authors
Göttgens, Berthold
Abstract
The development of blood cells has long served as a model system to study the generation of diverse mature cells from multipotent progenitors. The article by Org et al (2015) reveals how transcription factor competition on primed DNA templates may contribute to embryonic blood cell specification during the early stages of mesoderm development. The study not only provides new insights into the functionality of the key haematopoietic transcription factor Scl/Tal1, but also provides a potentially widely applicable framework for transcription factor-mediated cell fate specification.
Description
Keywords
Basic Helix-Loop-Helix Transcription Factors, Cell Differentiation, Enhancer Elements, Genetic, Gene Expression Regulation, Developmental, Hematopoietic Stem Cells, Humans, Mesoderm, Myoblasts, Cardiac, Proto-Oncogene Proteins, T-Cell Acute Lymphocytic Leukemia Protein 1
Journal Title
EMBO J
Conference Name
Journal ISSN
0261-4189
1460-2075
1460-2075
Volume Title
34
Publisher
Wiley-VCH Verlag
Publisher DOI
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/I00050X/1)
Medical Research Council (G0900951)
Cancer Research Uk (None)
Leukaemia & Lymphoma Research (12029)
Wellcome Trust (097922/Z/11/Z)
Medical Research Council (MC_PC_12009)
Leukemia & Lymphoma Society (7001-12)
National Centre for the Replacement Refinement and Reduction of Animals in Research (G0900729/1)
Wellcome Trust (097922/Z/11/B)
Medical Research Council (G0900951/1)
Medical Research Council (G0900951)
Cancer Research Uk (None)
Leukaemia & Lymphoma Research (12029)
Wellcome Trust (097922/Z/11/Z)
Medical Research Council (MC_PC_12009)
Leukemia & Lymphoma Society (7001-12)
National Centre for the Replacement Refinement and Reduction of Animals in Research (G0900729/1)
Wellcome Trust (097922/Z/11/B)
Medical Research Council (G0900951/1)
Research in the author’s laboratory is supported by Cancer Research UK, BBSRC, MRC, Leukaemia and Lymphoma Research, Leukemia and Lymphoma Society, Microsoft Research and core support grants from the Wellcome Trust to the Cambridge Institute for Medical Research and Wellcome Trust–MRC Cambridge Stem Cell Institute.